markers CD64
Showing 1 - 25 of >10,000
Neonatal Sepsis Trial in Sohag (CD64 , HLA-DR)
Not yet recruiting
- Neonatal Sepsis
- CD64 , HLA-DR
-
Sohag, EgyptSohag University hospitals
Aug 7, 2023
Immune Markers in Pediatric ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
- (no location specified)
Oct 17, 2023
CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations
Completed
- Cystic Fibrosis
-
Denver, ColoradoNational Jewish Health
Aug 31, 2021
Neutrophil CD64 and Procalcitonin as Novel Biomarkers for
Completed
- Bacterial Infection
- +2 more
- CD64 and Procalcitonin
-
Oslo, Lorenskog, NorwayAkershus University Hospital
Aug 11, 2021
Hiv Trial in Nice (plasma inflammatory markers, CD4/CD8 ratio)
Not yet recruiting
- Hiv
- plasma inflammatory markers
- CD4/CD8 ratio
-
Nice, FranceCHU Nice
Jan 16, 2023
Endometrial Cancer Treatment Development
Completed
- Endometrial Cancer Stage
-
Yunusemre, Mani̇sa, TurkeyManisa Celal Bayar University
Jun 13, 2023
Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte (biological, drug, procedure, other)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- +2 more
- Daratumumab
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
Postoperative Infectious Complications in Colorectal Cancer
Completed
- Colorectal Cancer
-
Moscow, Russian FederationState Scientific Centre of Coloproctology
Sep 21, 2021
CD34 + Stem Cells and Biological Markers of Angiogenesis in
Recruiting
- Vasculopathy
- Heart Transplant Failure
- coronary CT angiography
-
Ljubljana, SloveniaAdvanced Heart Failure and Transplantation Center, University Me
Aug 2, 2022
B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Cyclophosphamide injection
- +2 more
-
Charleston, South CarolinaHollings Cancer Center at Medical University of South Carolina
Jan 18, 2023
Periodontal and Peri-implant Health and Disease
Completed
- Peri-Implantitis
- Periodontitis
-
Istanbul, TurkeyBiruni University
Feb 7, 2022
Role of Inflammatory Markers in Sepsis
Not yet recruiting
- Diagnostic
- Serology tests
-
Cairo, EgyptWalaa Y Elsabeeny
Oct 26, 2023
COVID-19 Trial in Sohag (real time PCR)
Recruiting
- COVID-19
- real time PCR
-
Sohag, EgyptSohag University Hospital
Jan 20, 2022
COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in
Not yet recruiting
- Follicular Lymphoma
- Cellular immunity vs SARS-CoV-2
- +6 more
-
Alessandria, IT, Italy
- +13 more
Oct 10, 2023
Unfavorable Course of Sepsis in Children Based onComprehensive
Recruiting
- Sepsis
- flow cytometry
- +2 more
-
Minsk, BelarusRepublican Research and Practical Centre for Epidemiology and Mi
Nov 15, 2023
sTREM-1, PCT and CD64 in Diagnosing Sepsis
Completed
- Critically Ill Patients
-
Dijon, France
- +1 more
Sep 16, 2020
Combination of Leukocyte Cell Surface Biomarkers Measured by
Not yet recruiting
- Bacterial and Viral Infections
- 2 additional whole blood samples of 6mL each will be taken
- (no location specified)
Nov 30, 2023
Roles of Some Non-classic Biomarkers in Pediatric Pneumonia
Not yet recruiting
- Pneumonia in Children
- (no location specified)
Jan 25, 2023
AOrtic Surgery: Systemic Inflammatory Response Versus Sepsis
Recruiting
- Systemic Inflammatory Response Syndrome
- +4 more
- Blood sample test
- Thoracic Aortic Surgery
-
Hradec Králové, Královehradecký Kraj, CzechiaUniversity Hospital Hradec Králové
Aug 31, 2023
Formation of HIV Cellular Reservoirs Through Expression of
Completed
- HIV Infections
- Blood sample
-
Montpellier, FranceMonsef BENKIRANE
Dec 4, 2020
Ulcerative Colitis or Crohn's Disease Receiving Vedolizumab in
Recruiting
- Inflammatory Bowel Disease (IBD)
- +2 more
-
Wroclaw, Dolnoslskie, Poland
- +10 more
Sep 12, 2022
Unfavorable Course of Sepsis in Children
Recruiting
- Sepsis
- Bood leukocyte subsets
-
Minsk, BelarusCity Children's Infectious Clinical Hospital
Jun 8, 2023
HER2 Positive Breast Carcinoma, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Duarte (radiation, other,
Active, not recruiting
- HER2 Positive Breast Carcinoma
- +3 more
- Copper Cu 64-DOTA-Trastuzumab
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 17, 2021
Neonatal Early-onset Sepsis, Neonatal Late-onset Sepsis Trial in New Haven (Intervention is to stop antibiotics at 24h .)
Withdrawn
- Neonatal Early-onset Sepsis
- Neonatal Late-onset Sepsis
- Intervention is to stop antibiotics at 24h .
-
New Haven, ConnecticutYale-New Haven Children's Hospital NICU
Mar 27, 2020